Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Total Non-Current Liabilities (2017 - 2025)

Entera Bio has reported Total Non-Current Liabilities over the past 9 years, most recently at $689000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities rose 414.18% year-over-year to $689000.0, compared with a TTM value of $689000.0 through Dec 2025, up 414.18%, and an annual FY2025 reading of $689000.0, up 414.18% over the prior year.
  • Total Non-Current Liabilities came in at $689000.0 for Q4 2025, up from $602000.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $689000.0 in Q4 2025 to a low of $32000.0 in Q4 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $258000.0 (2021), compared with a mean of $285200.0.
  • The sharpest move saw Total Non-Current Liabilities plummeted 87.74% in 2022, then surged 800.0% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $261000.0 in 2021, then plummeted by 87.74% to $32000.0 in 2022, then surged by 800.0% to $288000.0 in 2023, then plummeted by 53.47% to $134000.0 in 2024, then surged by 414.18% to $689000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Total Non-Current Liabilities are $689000.0 (Q4 2025), $602000.0 (Q3 2025), and $567000.0 (Q2 2025).